Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma.

Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet ISSN: 1099-0461 (Electronic) Linking ISSN: 10956670 NLM ISO Abbreviation: J Biochem Mol Toxicol Subsets: MEDLINE

Original Publication: New York, NY : Wiley, c1998-

Chalcones*/pharmacology ; Antineoplastic Agents*/pharmacology ; Chalcone* ; Carcinoma* ; Benzimidazoles* ; Carbocyanines*; Humans ; Prolyl Hydroxylases ; Acridine Orange ; Apoptosis ; Tumor Microenvironment

Normoxic inactivation of prolyl hydroxylase-2 (PHD-2) in tumour microenvironment paves the way for cancer cells to thrive under the influence of HIF-1α and NF-κB. Henceforth, the present study is aimed to identify small molecule activators of PHD-2. A virtual screening was conducted on a library consisting of 265,242 chemical compounds, with the objective of identifying molecules that exhibit structural similarities to the furan chalcone scaffold. Further, PHD-2 activation potential of screened compound was determined using in vitro 2-oxoglutarate assay. The cytotoxic activity and apoptotic potential of screened compound was determined using various staining techniques, including 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, 4',6-diamidino-2-phenylindole (DAPI), 1,1',3,3'-tetraethylbenzimi-dazolylcarbocyanine iodide (JC-1), and acridine orange/ethidium bromide (AO/EB), against MCF-7 cells. 7,12-Dimethylbenz[a]anthracene (DMBA) model of mammary gland cancer was used to study the in vivo antineoplastic efficacy of screened compound. [(E)-1-(4-fluorophenyl)-3-(furan-2-yl) prop-2-en-1-one] (BBAP-7) was screened and validated as a PHD-2 activator by an in vitro 2-oxo-glutarate assay. The IC 50 of BBAP-7 on MCF-7 cells is 18.84 µM. AO/EB and DAPI staining showed nuclear fragmentation, blebbing and condensation in MCF-7 cells following BBAP-7 treatment. The red-to-green intensity ratio of JC-1 stained MCF-7 cells decreased after BBAP-7 treatment, indicating mitochondrial-mediated apoptosis. DMBA caused mammary gland dysplasia, duct hyperplasia and ductal carcinoma in situ. Carmine staining, histopathology, and scanning electron microscopy demonstrated that BBAP-7, alone or with tirapazamine, restored mammary gland surface morphology and structural integrity. Additionally, BBAP-7 therapy significantly reduced oxidative stress and glycolysis. The findings reveal that BBAP-7 activates PHD-2, making it a promising anticancer drug.
(© 2024 Wiley Periodicals LLC.)

H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA Cancer J. Clin. 2021, 71(3), 209.
J. Ferlay, M. Colombet, I. Soerjomataram, D. M. Parkin, M. Piñeros, A. Znaor, F. Bray, Int. J. Cancer 2021, 149(4), 778.
Y. Feng, M. Spezia, S. Huang, C. Yuan, Z. Zeng, L. Zhang, X. Ji, W. Liu, B. Huang, W. Luo, B. Liu, Y. Lei, S. Du, A. Vuppalapati, H. H. Luu, R. C. Haydon, T. C. He, G. Ren, Genes Diseases 2018, 5(2), 77.
B. Muz, P. de la Puente, F. Azab, A. K. Azab, Hypoxia 2015, 3, 83.
B. Wielockx, A. Meneses, Hypoxia 2016, 4, 53.
L. Wang, Z. Niu, X. Wang, Z. Li, Y. Liu, F. Luo, X. Yan, Life Sci. 2020, 242, 117167.
E. R. Watts, S. R. Walmsley, Trends Mol. Med. 2019, 25(1), 33.
D. A. Chan, A. J. Giaccia, Br. J. Cancer 2010, 103(1), 1.
Y. Badawi, H. Shi, Front. Neurosci. 2017, 11(May), 1.
P. Mallikarjuna, Y. Zhou, M. Landström, Biomolecules 2022, 12(5), 635.
G. Lee, H. S. Won, Y. M. Lee, J. W. Choi, T. I. Oh, J. H. Jang, D.-K. Choi, B.-O. Lim, Y. J. Kim, J.-W. Park, P. Puigserver, J.-H. Lim, Sci. Rep. 2016, 6, 18928.
A. M. Kozlov, A. Lone, D. H. Betts, R. C. Cumming, Sci. Rep. 2020, 10(1), 8388.
E. Temes, S. Martín-Puig, B. Acosta-Iborra, M. C. Castellanos, M. Feijoo-Cuaresma, G. Olmos, J. Aragonés, M. O. Landazuri, J. Biol. Chem. 2005, 280(25), 24238.
M. Nepal, Y. D. Gong, Y. R. Park, Y. Soh, Cell Biochem. Funct. 2011, 29(2), 126.
H. J. Choi, B. J. Song, Y. D. Gong, W. J. Gwak, Y. Soh, Br. J. Pharmacol. 2008, 154(1), 114.
U. Devi, M. Singh, S. Roy, A. C. Tripathi, P. S. Gupta, S. K. Saraf, M. N. Ansari, A. S. Saeedan, G. Kaithwas, Naunyn-Schmiedeberg's Arch. Pharmacol. 2019, 392(10), 1239.
M. Singh, U. Devi, S. Roy, P. S. Gupta, G. Kaithwas, RSC Adv. 2018, 8(23), 12848.
M. T. Helmy, F. M. Sroor, K. F. Mahrous, K. Mahmoud, H. M. Hassaneen, F. M. Saleh, I. A. Abdelhamid, M. A. Mohamed Teleb, Arch. Pharm. 2022, 355, e2100381.
B. Srinivasan, T. E. Johnson, C. Xing, Bioorg. Med. Chem. Lett. 2011, 21(1), 555.
A. A. WalyEldeen, S. Sabet, H. M. El-Shorbagy, I. A. Abdelhamid, S. A. Ibrahim, Chemico-Biological Interactions 2023, 369, 110297.
T. Constantinescu, C. N. Lungu, Int. J. Mol. Sci. 2021, 22(21), 11306.
D. Albano, M. Benenati, A. Bruno, F. Bruno, M. Calandri, D. Caruso, D. Cozzi, R. De Robertis, F. Gentili, I. Grazzini, G. Micci, A. Palmisano, C. Pessina, P. Scalise, F. Vernuccio, A. Barile, V. Miele, R. Grassi, C. Messina, D. Albano, M. Benenati, A. Bruno, F. Bruno, M. Calandri, D. Caruso, D. Cozzi, R. De Robertis, F. Gentili, I. Grazzini, G. Micci, A. Palmisano, C. Pessina, P. Scalise, F. Vernuccio, C. Messina, Insights Imaging 2021, 12(1), 76.
Y. Ouyang, J. Li, X. Chen, X. Fu, S. Sun, Q. Wu, Biomolecules 2021, 11(6), 894.
S. B. Reddy, S. K. Williamson, Expert Opin. Invest. Drugs 2009, 18(1), 77.
L. A. McNeill, L. Bethge, K. S. Hewitson, C. J. Schofield, Anal. Biochem. 2005, 336(1), 125.
S. J. Wong, A. E. Ringel, W. Yuan, J. A. Paulo, H. Yoon, M. A. Currie, M. C. Haigis, J. Biol. Chem. 2021, 296, 100397.
E. M. El-Fakharany, M. M. Abu-Serie, A. Ibrahim, M. Eltarahony, Sci. Rep. 2023, 13(1), 9579.
A. Habibi, S. A. Sadat Shandiz, A. salehzadeh, Z. Moradi-Shoeili, JBIC, J. Biol. Inorg. Chem. 2020, 25(1), 13.
K. Laka, L. Makgoo, Z. Mbita, Genes 2019, 10(1), 41.
R. Prasad, B. Koch, J Cytol Histol 2016, 7(4), 1000432. https://doi.org/10.4172/2157-7099.1000432.
S. Roy, A. K. Rawat, S. R. Sammi, U. Devi, M. Singh, S. Gautam, R. K. Yadav, J. K. Rawat, L. Singh, M. N. Ansari, A. S. Saeedan, R. Pandey, D. Kumar, G. Kaithwas, Oncotarget 2017, 8(41), 70049.
J. K. Rawat, S. Roy, M. Singh, S. Guatam, R. K. Yadav, M. N. Ansari, S. A. Aldossary, A. S. Saeedan, G. Kaithwas, Front. Pharmacol. 2019, 10(May), 1.
S. R. Sammi, J. K. Rawat, N. Raghav, A. Kumar, S. Roy, M. Singh, S. Gautam, R. K. Yadav, U. Devi, R. Pandey, G. Kaithwas, Eur. J. Pharmacol. 2018, 818, 174.
L. Singh, S. Roy, A. Kumar, S. Rastogi, D. Kumar, M. Ansari, A. S. Saeedan, M. Singh, G. Kaithwas, Front. Cell. Dev. Biol. 2021, 9, 736910.
A. Rani, S. Roy, M. Singh, U. Devi, R. K. Yadav, S. Gautam, J. K. Rawat, M. N. Ansari, A. S. Saeedan, A. Prakash, G. Kaithwas, Inflammopharmacology. 2016, 24(5), 277.
M. Singh, S. Kasna, S. Roy, S. Aldosary, A. S. Saeedan, M. N. Ansari, G. Kaithwas, BMC Cancer 2019, 19(1), 996.
S. Gautam, P. Singh, M. Singh, S. Roy, J. K. Rawat, R. K. Yadav, U. Devi, P. S. Gupta, S. A. Saraf, G. Kaithwas, RSC Adv. 2018, 8(7), 3512.
G. Kaithwas, P. Singh, D. Bhatia, Drug Chem. Toxicol. 2014, 37(2), 135.
A. Z. Reznick, L. Packer, Methods Enzymol. 1994, 233, 357.
H. Ohkawa, N. Ohishi, K. Yagi, Anal. Biochem. 1979, 95(2), 351.
M. Ghasemi, T. Turnbull, S. Sebastian, I. Kempson, Int. J. Mol. Sci. 2021, 22(23), 12827.
K. Liu, P. Liu, R. Liu, X. Wu, Med. Sci. Monit. Basic Res. 2015, 21, 15.
A. Dutta, T. Panchali, A. Khatun, S. R. Jarapala, K. Das, K. Ghosh, S. Chakrabarti, S. Pradhan, Sci. Rep. 2023, 13(1), 14125.
S. Z. A. Khader, S. Syed Zameer Ahmed, G. M. Ganesan, M. R. Mahboob, M. Vetrivel, M. Sankarappan, P. Manickam, Environ. Sci. Pollut. Res. 2020, 27(2), 2155.
A. Perelman, C. Wachtel, M. Cohen, S. Haupt, H. Shapiro, A. Tzur, Cell Death Dis. 2012, 3(11), e430.
D. R. Green, J. C. Reed, Science 1998, 281(5381), 1309.
F. Sivandzade, A. Bhalerao, L. Cucullo, Bio-Protocol. 2019, 9(1), 1.
S. D. Bernal, H. M. Shapiro, L. B. Chen, Int. J. Cancer 1982, 30(2), 219.
S. G. Lakoski, L. W. Jones, R. J. Krone, P. K. Stein, J. M. Scott, Am. Heart J. 2015, 170(2), 231.
N. Nandakumar, M. P. Balasubramanian, J. Environ. Pathol. Toxicol. Oncol. 2011, 30(4), 283.
D. Krishnamoorthy, M. Sankaran, J. Cancer Res. Ther. 2016, 12(1), 386.
G. Y. Liou, P. Storz, Free Radical Res. 2010, 44, 479.
V. Aggarwal, H. Tuli, A. Varol, F. Thakral, M. Yerer, K. Sak, M. Varol, A. Jain, M. Khan, G. Sethi, Biomolecules 2019, 9(11), 735.
A. A. Hamza, M. A. Khasawneh, H. M. Elwy, S. O. Hassanin, S. F. Elhabal, N. M. Fawzi, Biomed. Pharmacother. 2022, 147, 112666.
Z. Wang, X. Zhang, Front. Pharmacol. 2017, 8, 1.
C. J. Weydert, J. J. Cullen, Nat. Protoc. 2010, 5(1), 51.
S. de Assis, A. Warri, M. Idalia Cruz, L. Hilakivi-Clarke, J. Vis. Exp. 2010, 44, 1.
G. L. Gierach, D. A. Patel, R. M. Pfeiffer, J. D. Figueroa, L. Linville, D. Papathomas, J. M. Johnson, R. E. Chicoine, S. D. Herschorn, J. A. Shepherd, J. Wang, S. Malkov, P. M. Vacek, D. L. Weaver, B. Fan, A. P. Mahmoudzadeh, M. Palakal, J. Xiang, H. Oh, H. N. Horne, B. L. Sprague, S. M. Hewitt, L. A. Brinton, M. E. Sherman, Cancer Prev. Res. 2016, 9(2), 149.
Y. Machida, T. Imai, Oncol. Lett. 2021, 22(4), 738.
K. C. Karnam, M. Ellutla, L. N. Bodduluru, E. R. Kasala, S. K. Uppulapu, M. Kalyankumarraju, M. Lahkar, Biomed. Pharmacother. 2017, 92, 207.
S. Roy, M. Singh, A. Rawat, U. Devi, S. Gautam, R. K. Yadav, J. K. Rawat, M. N. Ansari, A. S. Saeedan, D. Kumar, G. Kaithwas, Int. J. Biochem. Cell. Biol. 2018, 96, 51.
C. Manral, S. Roy, M. Singh, S. Gautam, R. K. Yadav, J. K. Rawat, U. Devi, M. N. Ansari, A. S. Saeedan, G. Kaithwas, BMC Complement. Altern. Med. 2016, 16(1), 260.
M. Jang, S. S. Kim, J. Lee, Exp. Mol. Med. 2013, 45(10), e45.
S. Rastogi, S. Aldosary, A. S. Saeedan, M. N. Ansari, M. Singh, G. Kaithwas, Front Pharmacol. 2023, 14, 1108915.
D. Singh, S. Thakur, D. Singh, H. S. Buttar, B. Singh, S. Arora, Front. Pharmacol. 2021, 12, 1.
E. Kocianova, V. Piatrikova, T. Golias, Cancers 2022, 14(24), 6028.

Keywords: DMBA; MCF-7; PHD-2 activator; breast cancer; hypoxia

EC 1.14.11.- (Prolyl Hydroxylases)
0 (Chalcones)
21527-78-6 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine)
0 (Antineoplastic Agents)
F30N4O6XVV (Acridine Orange)
5S5A2Q39HX (Chalcone)
0 (Benzimidazoles)
0 (Carbocyanines)

Date Created: 20240315 Date Completed: 20240318 Latest Revision: 20240318

20240318

10.1002/jbt.23679

38486411